Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Brisson

Showing results (101-110 of 145) with videos related to

Pageof 15
Sort By:
Vaccine|August 14, 2022
Human papillomavirus vaccine effectiveness by number of doses: Updated systematic review of data from national immunization programsLauri E Markowitz, Mélanie Drolet, Rayleen M Lewis, et al.
Vaccine|July 9, 2013
Comparative cost-effectiveness of the quadrivalent and bivalent human papillomavirus vaccines: a transmission-dynamic modeling studyMarc Brisson, Jean-François Laprise, Mélanie Drolet, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 29, 2020
The role of case importation in explaining differences in early SARS-CoV-2 transmission dynamics in Canada-A mathematical modeling study of surveillance dataArnaud Godin, Yiqing Xia, David L Buckeridge, et al.
Journal of the National Cancer Institute. Monographs|November 12, 2024
Population-level impact of switching to 1-dose human papillomavirus vaccination in high-income countries: examining uncertainties using mathematical modelingMarc Brisson, Jean-François Laprise, Mélanie Drolet, et al.
Vaccine|August 8, 2022
Recent economic evaluation of 1-dose HPV vaccination uses unsupported assumptionsEmily Burger, Iacopo Baussano, Jane J Kim, et al.
Infectious Agents and Cancer|November 8, 2023
Association of naturally acquired type-specific HPV antibodies and subsequent HPV re-detection: systematic review and meta-analysisKana Yokoji, Katia Giguère, Talía Malagón, et al.
Vaccine|December 25, 2019
Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to no vaccination or standard three and two-dose vaccination regimens: A systematic review of evidence from clinical trialsHilary S Whitworth, Katherine E Gallagher, Natasha Howard, et al.
Journal of the National Cancer Institute|June 15, 2013
ResponseMarc Brisson, Mélanie Drolet, Marie-Claude Boily, et al.
Journal of the National Cancer Institute|October 30, 2012
Population-level impact of the bivalent, quadrivalent, and nonavalent human papillomavirus vaccines: a model-based analysisNicolas Van de Velde, Marie-Claude Boily, Mélanie Drolet, et al.
The Lancet. Healthy Longevity|July 17, 2023
Effectiveness of previous infection-induced and vaccine-induced protection against hospitalisation due to omicron BA subvariants in older adults: a test-negative, case-control study in Quebec, CanadaSara Carazo, Danuta M Skowronski, Marc Brisson, et al.
Pageof 15

Showing results (101-110 of 145) with videos related to

Sort By:
Pageof 15
Vaccine|August 14, 2022
Human papillomavirus vaccine effectiveness by number of doses: Updated systematic review of data from national immunization programsLauri E Markowitz, Mélanie Drolet, Rayleen M Lewis, et al.
Vaccine|July 9, 2013
Comparative cost-effectiveness of the quadrivalent and bivalent human papillomavirus vaccines: a transmission-dynamic modeling studyMarc Brisson, Jean-François Laprise, Mélanie Drolet, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 29, 2020
The role of case importation in explaining differences in early SARS-CoV-2 transmission dynamics in Canada-A mathematical modeling study of surveillance dataArnaud Godin, Yiqing Xia, David L Buckeridge, et al.
Journal of the National Cancer Institute. Monographs|November 12, 2024
Population-level impact of switching to 1-dose human papillomavirus vaccination in high-income countries: examining uncertainties using mathematical modelingMarc Brisson, Jean-François Laprise, Mélanie Drolet, et al.
Vaccine|August 8, 2022
Recent economic evaluation of 1-dose HPV vaccination uses unsupported assumptionsEmily Burger, Iacopo Baussano, Jane J Kim, et al.
Infectious Agents and Cancer|November 8, 2023
Association of naturally acquired type-specific HPV antibodies and subsequent HPV re-detection: systematic review and meta-analysisKana Yokoji, Katia Giguère, Talía Malagón, et al.
Vaccine|December 25, 2019
Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to no vaccination or standard three and two-dose vaccination regimens: A systematic review of evidence from clinical trialsHilary S Whitworth, Katherine E Gallagher, Natasha Howard, et al.
Journal of the National Cancer Institute|June 15, 2013
ResponseMarc Brisson, Mélanie Drolet, Marie-Claude Boily, et al.
Journal of the National Cancer Institute|October 30, 2012
Population-level impact of the bivalent, quadrivalent, and nonavalent human papillomavirus vaccines: a model-based analysisNicolas Van de Velde, Marie-Claude Boily, Mélanie Drolet, et al.
The Lancet. Healthy Longevity|July 17, 2023
Effectiveness of previous infection-induced and vaccine-induced protection against hospitalisation due to omicron BA subvariants in older adults: a test-negative, case-control study in Quebec, CanadaSara Carazo, Danuta M Skowronski, Marc Brisson, et al.
Pageof 15